The Impact of the Withdrawal of Propoxyphene from the U. S. Market

dc.contributor.authorHebda, Michele
dc.contributor.authorSiracuse, Mark V.
dc.contributor.cuauthorHebda, Michele
dc.contributor.cuauthorSiracuse, Mark V.
dc.date.accessioned2012-04-15T21:28:07Z
dc.date.available2012-04-15T21:28:07Z
dc.date.issued2012-03-28
dc.description.abstractTo determine the clinical and economic impact of the withdrawal of propoxyphene from the U.S. market. Using a proprietary data set we:  Determined the prescription products that patients were switched to following withdrawal of propoxyphene.  Determined the cost of the prescription products that patients were switched to.en_US
dc.identifier.urihttp://hdl.handle.net/10504/27959
dc.program.unitSchool of Pharmacyen_US
dc.publisherCreighton Universityen_US
dc.rights.holderMichele Hebdaen_US
dc.rights.holderMark V. Siracuseen_US
dc.subject.lcshPrescription drugsen_US
dc.subject.lcshDrug toxicityen_US
dc.subject.lcshPain relieversen_US
dc.titleThe Impact of the Withdrawal of Propoxyphene from the U. S. Marketen_US
dc.typeGenericen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Michele Hebda Withdrawal of Propoxyphene.pdf
Size:
154.05 KB
Format:
Adobe Portable Document Format
Description:
PDF
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Collections